Moore Simas, Tiffany A Huang, Ming-Yi Packnett, Elizabeth R Zimmerman, Nicole M Moynihan, Meghan Eldar-Lissai, Adi
Published in
Journal of medical economics
Objective: To assess healthcare resource utilization (HRU) and costs in children of mothers with and without postpartum depression (PPD).Methods: Administrative claims data from the IBM Watson Health MarketScan Databases (2010-2016) were used. Women with live births (index date = delivery date) were identified and linked to their newborns. The moth...
Potter, Brian J Ann Thompson, Christin
Published in
Journal of medical economics
Background: Procedural efficiencies can contribute to cost reductions in transcatheter aortic valve replacement procedures (TAVR). The objective of this study is to determine operating room (OR) variable cost per minute in endovascular TAVR procedures, in a real-world hospital setting. Methods: Using Premier data from January 2015-June 2016 for pat...
van Mastrigt, Ghislaine A Evers, Silvia M Heerings, Marco Visser, Leo H Ruimschotel, Rob P Hussaarts, Astrid Duyverman, Lotte Valkenburg-Vissers, Joyce Cornelissen, Job Bos, Michel
...
Published in
Journal of medical economics
Aims: This trial-based economic evaluation (EE) assesses from a societal perspective the cost-effectiveness of an intensive 3-day cognitive theory-based intervention (CDT), compared to care-as-usual, in patients with relapsing remitting multiple sclerosis (RRMS) and low disability (Expanded Disability Status Scale [EDDS] score
Bensimon, Arielle G Zhou, Zheng-Yi Jenkins, Madeline Song, Yan Gao, Wei Signorovitch, James Krepler, Clemens Liu, Frank Xiaoqing Wang, Jingshu Aguiar-Ibáñez, Raquel
...
Published in
Journal of medical economics
Aims: To evaluate the cost-effectiveness of adjuvant pembrolizumab relative to observation alone following complete resection of high-risk stage III melanoma with lymph node involvement, from a US health system perspective. Materials and methods: A Markov cohort model with four health states (recurrence-free, locoregional recurrence, distant metast...
Lee, Vivian Wy Cheng, Franco Wt
Published in
Journal of medical economics
Igarashi, Ataru Goto, Rei Yoneyama-Hirozane, Mariko
Published in
Journal of medical economics
Objectives: Theoretically, willingness-to-pay (WTP) for quality-adjusted life years (QALY) can vary depending on social and personal preferences and on ex-ante and ex-post settings. However, empirical investigations into the theoretical differences are lacking. In Japan, setting the threshold has been controversial since a pilot project to implemen...
Davis, Joanna Yan, Songkai Matsushita, Tadashi Alberio, Lorenzo Bassett, Paul Santagostino, Elena
Published in
Journal of medical economics
Aims: Prophylaxis with standard-acting recombinant factor IX (rFIX) in hemophilia B patients requires frequent injections. Extended half-life (EHL) products allow for prolonged dosing intervals, and so reduce this treatment burden. Three technologies are employed to extend the half-life of FIX; glycopegylation, Fc-fusion, and albumin fusion. rIX-FP...
Darbà, Josep
Published in
Journal of medical economics
Background: Phenylketonuria is a well-known disease, yet the characteristics of the affected population and their use of healthcare resources have not been comprehensively evaluated. Patient characteristics and use of resources are subjects of interest for most governments, especially for a disease included in newborn screening programs. Objective:...
Guzauskas, Gregory F Pollom, Erqi L Stieber, Volker W Wang, Bruce C M Garrison, Louis P Jr
Published in
Journal of medical economics
Purpose: The EF-14 trial demonstrated that adding tumor treating fields (TTFields) to maintenance temozolomide (TMZ) significantly extends progression-free survival (PFS) and overall survival (OS) for newly-diagnosed glioblastoma (GBM) patients. This study assessed the cost-effectiveness of TTFields and TMZ for newly-diagnosed GBM from the US healt...
Slater, Jeremy D Eaddy, Michael Butts, Conor M Meltser, Inna Murty, Sharanya
Published in
Journal of medical economics
Aims: Electroencephalography (EEG) is an established method to evaluate and manage epilepsy; video EEG (VEEG) has significantly improved its diagnostic value. This study compared healthcare costs and diagnostic-related outcomes associated with outpatient vs inpatient VEEG among patients with epilepsy in the US. Materials and methods: This study use...
